首页> 美国卫生研究院文献>Cancer Management and Research >The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

【2h】

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

机译：Epirubicin加环磷酰胺的新辅助化疗方案的疗效和毒性其次是女性乳腺癌患者的多西紫杉醇或紫杉醇

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Cancer Management and Research
作者
Xian Wu; Chaoran Ye; Xingmeng Wang; Ruyu Cai; Junzhe Yang; Xiafei Yu; Yi Zhou; Li Shen; Yanhui Zhu; Xiaoan Liu;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
neoadjuvant chemotherapy; pathological complete response; EC-D; EC-P; toxicity of anticancer drugs;

机译：Neoadjuvant化疗;病理完全反应;EC-D;EC-P;抗癌药物的毒性;

相似文献

外文文献
中文文献
专利

1. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer [J] . Minmin Zhang, Wei Wei, Jianlun Liu, OncoTargets and therapy . 2016,第1期

机译：在可手术乳腺癌患者中，新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
2. A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer [J] . Xin Yao, Janet Hosenpud, Christopher R. Chitambar, Journal of Cancer . 2012,第16期

机译：并发多西他赛，表柔比星和环磷酰胺作为局部晚期乳腺癌患者新辅助化疗方案的II期研究
3. The efficacy and safety of 4 cycles of tri-weekly nanoparticle albumin-bound paclitaxel (nab-PTX) followed by 4 cycles of FEC (5-fluorouracil, epirubicin, cyclophosphamide) as neoadjuvant chemotherapy for patients with HER2-negative primary breast cancer - A multicenter phase II study (KBCSG-TR1213) [J] . Tanaka K., Masuda N., Matsunami N., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Suppla2期

机译：三周期每周一次的纳米蛋白白蛋白结合紫杉醇（nab-PTX）的4周期，然后进行4周期FEC（5-氟尿嘧啶，表柔比星，环磷酰胺）作为HER2阴性原发性乳腺癌患者的新辅助化疗的疗效和安全性-A多中心II期研究（KBCSG-TR1213）
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer [O] . Yao, Xin, Hosenpud, Janet, Chitambar, Christopher R., 2012

机译：并发多西他赛，表柔比星和环磷酰胺作为局部晚期乳腺癌患者新辅助化疗方案的II期研究

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

著录项

引文网络

相似文献

相关主题

期刊订阅